Genedx Holdings Corp Share Price

NASDAQ: WGS

Small Cap

$127.89

+6.52

(+5.37%)

as on September 18, 2025 at 1:29 am IST

$₹

Genedx Holdings Corp Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$121.53
Day's Price Range
$129.47
$127.89
4.97%
Downside
1.24%
Upside
52 Week's Low
52 Week's High
$35.88
52-Week Price Range
$136
$127.89
71.94%
Downside
6.34%
Upside

Genedx Holdings Corp share price movements today

Previous Close: $121.37
Open: $121.53
Volume: 513.3K
Day's Low - High: $121.53 - $129.47
52 Week Low - High: $35.88 - $136

Genedx Holdings Corp Historical Returns

1 Month Return: + 1.6 %
3 Month Return: + 98.54 %
1 Year Return: + 229.95 %
3 Year Return: 0 %
5 Year Return: 0 %

Genedx Holdings Corp Stock Fundamentals & Key Indicators

Check Genedx Holdings Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5B

EPS (TTM)

1.795

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

1517.13

Industry PE ratio

0

P/B Ratio

1517.1251

PEG Ratio

0

EBITDA

29.6M

Revenue (TTM)

362.3M

Profit Margin

0.39%

Return On Equity TTM

0.60%

Genedx Holdings Corp Stock Valuation

Track how Genedx Holdings Corp P/E has moved over time to understand its valuation trends.

Genedx Holdings Corp in the last 5 years

Overview
Trends

Lowest (54.19x)

June 30, 2025

Industry (0.00x)

September 18, 2025

Today (1517.13x)

September 18, 2025

Highest (102.25x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 1517.13x

Genedx Holdings Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genedx Holdings Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Genedx Holdings Corp	BUY	$3.5B	NA	1517.13	0.39%
Idexx Laboratories, Inc.	BUY	$51.3B	80.65%	53.18	24.41%
Agilent Technologies Inc.	BUY	$35.9B	27.51%	29.54	17.97%
Iqvia Holdings Inc.	BUY	$31.7B	18.82%	27.1	7.88%
Thermo Fisher Scientific, Inc.	BUY	$178.5B	12.05%	27.32	15.24%

See all

Stock Returns calculator for Genedx Holdings Corp Stock including INR - Dollar returns

The Genedx Holdings Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y

Genedx Holdings Corp investment value today

Current value as on today

₹3,34,467

Returns

₹2,34,467

(+234.47%)

Returns from Genedx Holdings Corp Stock

₹2,29,868 (+229.87%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Genedx Holdings Corp Stock

Based on 8 analysts

BUY

62.50%

Buy

37.50%

Hold

0.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Genedx Holdings Corp. Average target price of $123.75

Genedx Holdings Corp Share Price Target

Get share price movements and forecasts by analysts on Genedx Holdings Corp.

What analysts predicted

-3.35%DOWNSIDE

Target Price

$123.75

Current Price

$127.89

Analyzed by

8 Analysts

Target

$123.75

Genedx Holdings Corp target price $123.75, a slight downside of -3.35% compared to current price of $127.89. According to 8 analysts rating.

Genedx Holdings Corp Stock's Interest Amongst Investors

Investment in Genedx Holdings Corp Shares on INDmoney has dropped by -5.47% over the past 30 days, indicating reduced transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:-5.47% versus previous 30 day period

Search interest for Genedx Holdings Corp Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-33% versus previous 30 day period

Genedx Holdings Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	43	48	53	57	62	70	76	95	87	102
Gross Profit	15	18	24	25	32	38	47	66	58	70
Operating Income	-58	-51	-42	-23	-12	-10	-7	8	-4	8
EBITDA	-50	-41	-26	-18	-14	-22	-1	11	-4	17
Interest Expense	0	0	-	0	0	0	0	0	0	0
Depreciation	8	10	8	6	5	5	5	5	5	6
Income Before Tax	-61	-46	-42	-26	-20	-29	-8	5	-6	10
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-60	-46	-42	-25	-20	-29	-8	5	-6	10
Net Profit Margin	-141.38%	-95.92%	-79.33%	-44.89%	-32.42%	-41.37%	-10.81%	5.69%	-7.49%	10.53%

Genedx Holdings Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	196	179	212	234	202	305
Gross Profit	82	4	-16	-26	60	194
Operating Income	-30	-241	-446	-667	-163	-23
EBITDA	-22	-224	-219	-398	-136	-27
Interest Expense	0	2	2	3	-	3
Depreciation	6	11	21	59	33	21
Income Before Tax	-29	-241	-245	-598	-176	-52
Income Tax Expense	1	5	21	-49	0	0
Net Income	-29	-241	-245	-548	-175	-52
Net Profit Margin	-15.14%	-134.58%	-115.64%	-233.91%	-86.77%	-17.12%

Genedx Holdings Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-46	-42	-25	-20	-29	-8	5	-6	-8
Operating Cash Flow	-53	-40	-29	-16	-4	-4	-3	10	10
Investing Cash Flow	-11	-27	-4	0	-22	-7	0	-9	-36
Financing Cash Flow	7	0	47	0	0	13	31	13	0
Change in Cash	-57	-69	12	-16	-27	1	27	14	-25

Genedx Holdings Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-241	-245	-548	-175	-52
Operating Cash Flow	-93	-190	-319	-180	-28
Investing Cash Flow	-31	-20	-141	-43	-30
Financing Cash Flow	129	493	197	186	44
Change in Cash	3	282	-263	-37	-14

Insights on Genedx Holdings Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 87.11M → 102.69M (in $), with an average increase of 15.2% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -6.52M → 10.80M (in $), with an average increase of 160.4% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WGS has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, WGS stock has moved up by 12082.9%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WGS has outperformed top 5 stocks with highest market-cap in its industry

About Genedx Holdings Corp

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

Organisation	Genedx Holdings Corp
Headquarters	North Tower, Stamford, CT, United States, 06902
Industry	Healthcare
CEO	Ms. Katherine A. Stueland
E-voting on shares	Click here to vote

Key Management of Genedx Holdings Corp

Name	Title
Ms. Katherine A. Stueland	President, CEO & Director
Mr. Kevin Feeley CPA	Chief Financial Officer
Dr. Bryan M. Dechairo Ph.D.	Chief Operating Officer
Ms. Heidi C. Chen J.D.	Chief Legal Officer
Ms. Jami Biliboaca	Head of People Strategy
Ms. Melanie Duquette	Chief Growth Officer
Dr. Martin G. Reese Ph.D.	President of Fabric Genomics

FAQs

What is Genedx Holdings Corp share price today?

Genedx Holdings Corp share price today is $127.89 as on September 18, 2025 at 1:29 am IST at the close of the market. Genedx Holdings Corp share today touched a day high of $129.47 and a low of $121.53.

What is the 52 week high and 52 week low for Genedx Holdings Corp share?

Genedx Holdings Corp share touched a 52 week high of $136 on September 8, 2025 and a 52 week low of $35.88 on September 25, 2024. Genedx Holdings Corp stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $127.89,which is 5.96% down from its 52 week high and 256.44% up from its 52 week low.

What is Genedx Holdings Corp's market capitalisation today?

Genedx Holdings Corp market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Genedx Holdings Corp Stock (WGS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Genedx Holdings Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genedx Holdings Corp Shares that will get you 0.0117 shares as per Genedx Holdings Corp share price of $127.89 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Genedx Holdings Corp Stock (WGS) from India?

Indian investors can start investing in Genedx Holdings Corp (WGS) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Genedx Holdings Corp stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:38 pm IST). Based on Genedx Holdings Corp share’s latest price of $127.89 as on September 18, 2025 at 1:29 am IST, you will get 0.0782 shares of Genedx Holdings Corp. Learn more about fractional shares .